Myocardial Infarction
Drug may hinder recovery from heart attacks
Published in Cardiovascular Week, January 17th, 2005
Researchers at the University of Alberta have discovered that a basic cellular process the body uses to balance pH in cells - also critical to recovery following a heart attack - is compromised by certain novel COX-2 inhibitors.
Bicarbonate transporters, enzymes critical to maintaining this delicate balance of bicarbonate across the cell membrane, are potently inhibited from doing their work by some clinically used nonsteroidal anti-inflammatory drugs such as celecoxib, the active ingredient in Celebrex.
Celecoxib is an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2005-01-17)
More Articles from Cardiovascular Week
- Antioxidants
Assay can be used to analyze or screen antioxidants against LDL oxidation - Atherosclerosis
Labedipinedilol-A may have potential in preventing progressive atherosclerosis - Collateral Arteries
Collateral recruitment has a major impact in the ischemic tolerance equation - Revascularization
Substantial differences exist concerning preoperative coronary revascularization - Statins
Participants appropriately self-selected OTC statin therapy - ACE Inhibitors
Coronary flow response to bradykinin is preserved by ACE inhibitors in aged mice - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
